Chyi-Hung Hsu, PhD, is a Director at Johnson & Johnsons Janssen R&D, specializing in statistical methodology for clinical drug development. His expertise covers pharmacokinetic/pharmacodynamic (PK/PD) modeling, Bayesian approaches, and adaptive trial designs to improve the efficiency of assessing drug efficacy and safety.
He applies advanced Bayesian statistical methods to pediatric pharmacokinetic studies, helping to improve drug development for children.
Chyi-Hung Hsu
Director at J&J PRD
Mendham, New Jersey, United States
Overview
Topics They Care About
PK/PD Modeling
His research focuses on pharmacokinetic and pharmacodynamic models to assess drug efficacy, dosing regimens, and exposure-response relationships in clinical trials.
Bayesian Methods
He specializes in applying Bayesian approaches to clinical trial design and subgroup analysis to enhance the efficiency and accuracy of drug development.
Adaptive Trial Design
He is involved in modernizing drug development through the use of adaptive designs, which can improve the efficiency and success rates of clinical studies.
Media Appearances
Chyi-Hung has no verified media appearances
Work History
Director at J&J PRD
Sr. Expert Stats Methodologist at Novartis
Education
Chyi-Hung has no verified education history
More Information
Social Presence :
Prographics :
Exp : N/A
Location : Mendham, New Jersey, United States
Job Level : Mid-senior
Designation : Director at J&J PRD
